You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日速報》恆指升682點; 恆生科技指數升174點 阿里巴巴升逾5% 騰訊升逾4% 美團升逾4% 網易、中廣核礦業、華晨中國、海通國際創新高 成交暢旺
恆指全日收18,079點,升682點或3.9%。恆生科技指數報4,125點,升174點或4.4%。國指升239點或4.0%,報6,204點。大市成交額1,349.49億元。 活躍重磅股表現: 阿里巴巴(09988.HK) 收83.2元,上升5.1%; 騰訊(00700.HK) 收322.6元,上升4.8%; 美團(03690.HK) 收113.3元,上升4.6%; 平安(02318.HK) 收39.55元,上升4.2%; 友邦(01299.HK) 收73.8元,上升3.5%; 港交所(00388.HK) 收295元,上升3.4%; 建行(00939.HK) 收4.63元,上升3.1%; 異動恆指及國指成份股: 創科(00669.HK) 收81.75元,上升10.5%; 京東物流(02618.HK) 收9.91元,上升8.4%; 小鵬汽車(09868.HK) 收67.8元,上升7.6%; 信義光能(00968.HK) 收5.31元,上升7.5%; 華潤萬象生活(01209.HK) 收31.2元,上升7%; 碧桂園服務(06098.HK) 收7.38元,上升6.6%; 舜宇(02382.HK) 收75.9元,上升6.6%; 京東集團(09618.HK) 收105.9元,上升6.4%; 恆隆地產(00101.HK) 收11.36元,上升6.4%; 藥明生物(02269.HK) 收50.7元,上升6.1%; 國壽(02628.HK) 收11.3元,上升6%; 小米集團(01810.HK) 收16.8元,上升5.9%; 龍湖(00960.HK) 收13.04元,上升5.8%; 信義玻璃(00868.HK) 收9.53元,上升5.8%; 領展房產基金(00823.HK) 收40.95元,上升5.7%; 蒙牛(02319.HK) 收25.95元,上升5.5%; 石藥(01093.HK) 收7.2元,上升5.4%; 招行(03968.HK) 收30.7元,上升5.3%; 紫金礦業(02899.HK) 收12.12元,上升5.2%; 理想汽車(02015.HK) 收159元,上升5.2%; 九龍倉置業(01997.HK) 收27.9元,上升5.1%; 京東健康(06618.HK) 收40.35元,上升5.1%; 新世界發展(00017.HK) 收15.6元,上升5%; 華潤置地(01109.HK) 收30.75元,上升4.9%; 中國海外發展(00688.HK) 收15.16元,上升4.7%; 中生製藥(01177.HK) 收3.82元,上升4.7%; 恆地(00012.HK) 收22.5元,上升4.7%; 中升控股(00881.HK) 收20.8元,上升4.5%; 中信股份(00267.HK) 收7.23元,上升4.5%; 長建(01038.HK) 收38.8元,上升4.4%; 百度集團-SW(09888.HK) 收108.4元,上升4.4%; 李寧(02331.HK) 收24.85元,上升4.4%; 申洲(02313.HK) 收86.15元,上升4.4%; 郵儲銀行(01658.HK) 收3.69元,上升4.2%; 吉利(00175.HK) 收9.69元,上升4.2%; 農夫山泉(09633.HK) 收46元,上升4.2%; 銀娛(00027.HK) 收43.2元,上升4%; 恆生(00011.HK) 收91.35元,上升3.9%; 百威亞太(01876.HK) 收16元,上升3.9%; 港鐵(00066.HK) 收30.45元,上升3.7%; 聯想集團(00992.HK) 收9.78元,上升3.7%; 新地(00016.HK) 收80.75元,上升3.7%; 周大福(01929.HK) 收12元,上升3.6%; 金沙(01928.HK) 收21.75元,上升3.6%; 阿里健康(00241.HK) 收4.98元,上升3.5%; 恆安(01044.HK) 收28.1元,上升3.5%; 中石化(00386.HK) 收4.2元,上升3.4%; 新奧能源(02688.HK) 收60.75元,上升3.4%; 快手-W(01024.HK) 收58.25元,上升3.3%; 工行(01398.HK) 收3.86元,上升3.2%; 華潤啤酒(00291.HK) 收41.9元,上升3.2%; 長和(00001.HK) 收40.85元,上升3.2%; 比亞迪(01211.HK) 收250.4元,上升3%; 網易(09999.HK) 收180元,上升3%,創新高; 異動綜合中小型股: 康寧傑瑞製藥(09966.HK) 收6.37元,下跌33.9%; 泉峯控股(02285.HK) 收21.05元,上升13.8%; 美圖(01357.HK) 收3.22元,下跌12.7%; 融創中國(01918.HK) 收2.3元,上升11.1%; 中廣核礦業(01164.HK) 收1.54元,上升2.7%,創新高; 華晨中國(01114.HK) 收4.06元,上升2.3%,創新高; 海通國際(00665.HK) 收1.44元,無升跌,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account